Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients

Poitiers University Hospital10,000 enrolled

Overview

National multicentric observational retrospective case-control study comparing the relative frequency of the various microorganisms responsible for VAP in patients infected or not by SARS-CoV-2 and their resistance to antibiotics.

Study Type

OBSERVATIONAL

Enrollment

10,000

Conditions

Ventilator Associated Pneumonia

Interventions

Bacterial species isolatedOTHER

in the respiratory specimen

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France. Exclusion Criteria: * All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Outcomes

Primary Outcomes

Prevalence of the microorganisms responsible for VAP among patients infected or not by the SARS-CoV-2

Time frame: 1 month

Secondary Outcomes

Prevalence of multi-drug resistant bacteria responsible for VAP among patients infected or not by the SARS-CoV-2

Time frame: 1 month

Central Contacts

Christophe BURUCOA

CONTACT

549443889 christophe.burucoa@chu-poitiers.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.